These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8717402)

  • 1. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens.
    Pouwels PH; Leer RJ; Boersma WJ
    J Biotechnol; 1996 Jan; 44(1-3):183-92. PubMed ID: 8717402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
    Li YG; Tian FL; Gao FS; Tang XS; Xia C
    Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of immune response after oral and intranasal immunization with recombinant Lactobacillus casei expressing ETEC F41].
    Liu J; Wei C; Hou X; Wang G; Yu L
    Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):524-30. PubMed ID: 19621642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Immunization with
    Li F; Wang X; Ma R; Wu W; Teng F; Cheng X; Jiang Y; Zhou H; Wang L; Tang L; Qiao X; Li Y
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains.
    Maassen CB; van Holten-Neelen C; Balk F; den Bak-Glashouwer MJ; Leer RJ; Laman JD; Boersma WJ; Claassen E
    Vaccine; 2000 May; 18(23):2613-23. PubMed ID: 10775795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7.
    Adachi K; Kawana K; Yokoyama T; Fujii T; Tomio A; Miura S; Tomio K; Kojima S; Oda K; Sewaki T; Yasugi T; Kozuma S; Taketani Y
    Vaccine; 2010 Apr; 28(16):2810-7. PubMed ID: 20170766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with recombinant Lactobacillus casei expressing flaB confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
    Kong YD; Kang YH; Tian JX; Zhang DX; Zhang L; Tao LT; Wu TL; Li Y; Wang GQ; Shan XF
    Fish Shellfish Immunol; 2019 Apr; 87():627-637. PubMed ID: 30708057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.
    Jiang X; Hou X; Tang L; Jiang Y; Ma G; Li Y
    Appl Microbiol Biotechnol; 2016 Sep; 100(17):7457-69. PubMed ID: 27020282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein.
    Liu D; Wang X; Ge J; Liu S; Li Y
    Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):73-81. PubMed ID: 20226529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.
    Maassen CB; Laman JD; den Bak-Glashouwer MJ; Tielen FJ; van Holten-Neelen JC; Hoogteijling L; Antonissen C; Leer RJ; Pouwels PH; Boersma WJ; Shaw DM
    Vaccine; 1999 Apr; 17(17):2117-28. PubMed ID: 10367944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
    Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
    Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with a Lactobacillus casei-based anti-porcine epidemic diarrhoea virus (PEDV) vaccine expressing microfold cell-targeting peptide Co1 fused with the COE antigen of PEDV.
    Wang XN; Wang L; Zheng DZ; Chen S; Shi W; Qiao XY; Jiang YP; Tang LJ; Xu YG; Li YJ
    J Appl Microbiol; 2018 Feb; 124(2):368-378. PubMed ID: 29178509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and immune efficacy of recombinant Lactobacillus casei strains expressing Malt from Aeromonas veronii.
    Ju AQ; Yang SB; Zhang HP; Ma X; Zhang DX; Kang YH; Shi QM; Wu TL; Wang GQ; Qian AD; Shan XF; Luan WM
    Microb Pathog; 2020 Apr; 141():103918. PubMed ID: 31935441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium.
    Ferreira PC; da Silva JB; Piazza RM; Eckmann L; Ho PL; Oliveira ML
    Clin Vaccine Immunol; 2011 Nov; 18(11):1823-33. PubMed ID: 21900533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactobacillus casei expressing OmpAI confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
    Zhang DX; Kang YH; Chen L; Siddiqui SA; Wang CF; Qian AD; Shan XF
    Fish Shellfish Immunol; 2018 Jan; 72():552-563. PubMed ID: 29155272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pMC11, a plasmid with dual origins of replication isolated from Lactobacillus casei MCJ and construction of shuttle vectors with each replicon.
    Chen Z; Lin J; Ma C; Zhao S; She Q; Liang Y
    Appl Microbiol Biotechnol; 2014 Jul; 98(13):5977-89. PubMed ID: 24652065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits.
    Zhao L; Guo Z; Liu J; Wang Z; Wang R; Li Y; Wang L; Xu Y; Tang L; Qiao X
    Vaccine; 2017 Jul; 35(32):4010-4021. PubMed ID: 28625525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections.
    Perdigón G; Alvarez S; Pesce de Ruiz Holgado A
    J Dairy Res; 1991 Nov; 58(4):485-96. PubMed ID: 1722492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of newly isolated probiotics in the protection against experimental intestinal trichinellosis.
    El Temsahy MM; Ibrahim IR; Mossallam SF; Mahrous H; Abdel Bary A; Abdel Salam SA
    Vet Parasitol; 2015 Dec; 214(3-4):303-14. PubMed ID: 26386829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of pyruvate and citrate in lactobacilli.
    Hickey MW; Hillier AJ; Jago GR
    Aust J Biol Sci; 1983; 36(5-6):487-96. PubMed ID: 6426447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.